Jpmorgan Chase & CO Aura Biosciences, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 53,502 shares of AURA stock, worth $438,716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,502
Previous 25,784
107.5%
Holding current value
$438,716
Previous $194,000
145.36%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AURA
# of Institutions
85Shares Held
37.6MCall Options Held
122KPut Options Held
38.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$56.8 Million2.94% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$47.6 Million0.91% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$40 Million0.08% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$24.9 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$24.6 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $240M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...